Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-019049
Filing Date
2025-07-02
Accepted
2025-07-02 16:20:24
Documents
1
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 form4-07022025_040717.html 4  
1 form4-07022025_040717.xml 4 6326
  Complete submission text file 0001415889-25-019049.txt   7788
Mailing Address 202 CARNEGIE CENTER SUITE 301 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 301 PRINCETON NJ 08540 646-885-8505
Y-mAbs Therapeutics, Inc. (Issuer) CIK: 0001722964 (see all company filings)

EIN.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SCOPIA CAPITAL MANAGEMENT LP 152 WEST 57TH STREET, 33RD FLOOR NEW YORK NY 10019
Business Address
TYAGI ASHU (Reporting) CIK: 0001752467 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38650 | Film No.: 251101387